» Articles » PMID: 39695092

The Effect of a New Developed Synbiotic Yogurt Consumption on Metabolic Syndrome Components in Adults with Metabolic Syndrome: a Randomized Controlled Clinical Trial

Overview
Journal Nutr Diabetes
Date 2024 Dec 18
PMID 39695092
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Studies have proposed that probiotic intake may ameliorate some of the clinical components of metabolic syndrome (MetS). This study aimed to determine the effects of a new developed synbiotic yogurt containing Lactobacillus plantarum, Lactobacillus pentosus, and Chloromyces marcosianos yeast on the components of MetS in adults with MetS.

Methods: In this randomized, placebo-controlled, clinical trial, 44 participants were divided into two groups to receive 300 grams of synbiotic yogurt or regular yogurt daily for 12 weeks. Anthropometric measurements, blood pressure, and biochemical parameters evaluated before and after the intervention.

Results: Daily consumption of synbiotic yogurt containing L. plantarum, L. pentosus, and C. marcosianos yeast in adults with MetS caused a significant decrease in the levels of fasting blood glucose (FBG) (p = 0.005), fasting insulin (p = 0.001), homeostatic model assessment for insulin resistance (HOMA-IR) index (p < 0.001), waist to hip ratio (WHR) (p = 0.02) and systolic blood pressure (p = 0.008) in the intervention group compared to the control group.

Conclusions: According to the findings of this study, daily consumption of the synbiotic yogurt was associated with improvements in insulin resistance, systolic blood pressure and WHR, which could be beneficial in patients with MetS.

References
1.
Esmaeilinezhad Z, Babajafari S, Sohrabi Z, Eskandari M, Amooee S, Barati-Boldaji R . Effect of synbiotic pomegranate juice on glycemic, sex hormone profile and anthropometric indices in PCOS: A randomized, triple blind, controlled trial. Nutr Metab Cardiovasc Dis. 2018; 29(2):201-208. DOI: 10.1016/j.numecd.2018.07.002. View

2.
Arabi S, Bahrami L, Rahnama I, Sahebkar A . Impact of synbiotic supplementation on cardiometabolic and anthropometric indices in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2022; 176:106061. DOI: 10.1016/j.phrs.2022.106061. View

3.
Campos-Perez W, Martinez-Lopez E . Effects of short chain fatty acids on metabolic and inflammatory processes in human health. Biochim Biophys Acta Mol Cell Biol Lipids. 2021; 1866(5):158900. DOI: 10.1016/j.bbalip.2021.158900. View

4.
He M, Shi B . Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci. 2017; 7:54. PMC: 5655955. DOI: 10.1186/s13578-017-0183-1. View

5.
Kazemi A, Soltani S, Ghorabi S, Keshtkar A, Daneshzad E, Nasri F . Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials. Clin Nutr. 2019; 39(3):789-819. DOI: 10.1016/j.clnu.2019.04.004. View